Publications found:
253,269
Sort by:
Conference Intelligence Dossier: EASD Annual Meeting 2009
US$ 995.00
The numbers are staggering: More than 200 million people around the world now suffer from diabetes and its major complications. According to the World Health Organization, that figure is expected to s...
October 2009
90 pages
The Pfizer Intelligence Dossier
US$ 295.00
In boardrooms, around water coolers and behind closed office doors, decision-makers in the pharmaceutical industry are asking questions: What’s happening with Pfizer? What developments have occurred i...
October 2009
60 pages
Pharma Sales Forces: Change in the Face of Adversity
US$ 395.00
“Change,” futurist Alvin Toffler once said, “is the process by which the future invades our lives.” For the pharmaceutical sales industry, that future is unfolding now. Dropping revenue, increasingly...
October 2009
40 pages
European Markets for Interventional Cardiology 2009 (15 Countries)
US$ 11,495.00
... 2008, the European market for interventional cardiology was valued at over €1.5 billion. The interventional cardiology market includes drug-eluting stents, ... devices, and IVUS catheters. In addition, this report covers the emerging markets for optical coherence tomography (OCT), vulnerable plaque screening, PFO ...
October 2009
409 pages
Japanese Market for Women's Health Devices 2009
US$ 7,495.00
... for women’s health devices was valued at over $234 million. Over 40% of the Japanese market for women’s health devices was accounted for by OB/GYN ultrasound imaging alone. The market for women’s health includes the segments and sub-segments for bone densitometry, breast biopsy, ...
October 2009
250 pages
European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
US$ 7,495.00
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: ...
October 2009
102 pages
Global Markets for Assisted Reproduction Devices 2010
US$ 11,495.00
Global Markets for Assisted Reproduction covers the U.S., 15 Countries in Europe and Japan. This report includes the Oocyte Retrieval Needle Market, Embryo Transfer Catheter Market and the Reproductive Media Market. The report includes procedure numbers, market forecasts and ...
October 2009
150 pages
Future of Green Biotechnology in China
US$ 9,683.00
... mentioned above are summarized specifically. - Overview of China’s green biotechnology: A higher level analysis and summary - Future ... in market, R&D and applications of China’s green biotechnology - Discover the potential opportunities for green biotechnology in China - Benefit from a thorough review of ...
October 2009
131 pages
Dental Eqquipment Growth in International Dental Industry
US$ 450.00
The present report on Dental Industry focuses on dental equipment market in United States also discusses markets in Europe and Asia. It gives an overview of the worldwide dental industry and its segme...
September 2009
32 pages
European Markets for Enteral Feeding Devices 2009 (Germany, France, U.K, Italy, Spain)
US$ 11,495.00
... market will reach €62.2 million by 2015. The market for enteral feeding devices in Europe is driven both by the very young and the elderly patient ... This trend is especially prevalent in France. This contributes the stability of the market, as the demand for the devices is distributed among different patient ...
September 2009
130 pages
European Markets for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 11,495.00
In 2008, the combined European market for dental bone graft substitutes and other biomaterials increased by 12.9% over 2007. The European market includes Austria, Benelux, France, Germany, Israel, Italy, Poland, Portugal, Scandinavia, Spain, Switzerland and ...
September 2009
545 pages
Austrian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Austrian market for dental bone graft substitutes grew by double digit rates. The 2008 average selling price was similar to the European average and can be expected to increase over the forecast period. Future growth will be driven by an increasing number of implant ...
September 2009
70 pages
Beneluxian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Beneluxian market for dental bone graft substitutes and other biomaterials, which includes Belgium, the Netherlands and Luxemburg, was the seventh largest in Europe in 2008. The Netherlands represented the vast majority of this market, which grew significantly in 2007. The rapid growth in the number of ...
September 2009
70 pages
French Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the French market for dental bone graft substitutes was the fourth largest in Europe. The 2008 average selling price for dental ... higher material costs and a lack of government and private insurance coverage. The French market will continue to see double digit growth driven by an increasing number of ...
September 2009
70 pages
Polish Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Polish market for dental bone graft substitutes and other biomaterials was the ninth largest in Europe. In 2008, growth in the number of ... implant procedures well into double digit rates over the forecast period. Poland is also associated with greater use of mineralized allografts, bolstered by demand for ...
September 2009
70 pages
Swiss Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Swiss market for dental bone graft substitutes and other biomaterials grew at double digit rates. While Switzerland has a relatively small population, it has one of the highest dental implant per capita rates in Europe, driving bone graft substitute use. ...
September 2009
70 pages
U.K. Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The U.K. market for dental bone graft substitutes and other biomaterials was the sixth largest in Europe in 2008. The market growth rate is predicted to be well above the European average over the forecast period. Average selling prices for dental bone ...
September 2009
70 pages
European Markets for Dental Dental Growth Factors 2009
US$ 4,495.00
The European markets for dental growth factors include the markets for emdogain, in addition to the markets for potential dental growth factors such as GEM-21S and INFUSE and Platelet Rich Plasma (PRP)
September 2009
69 pages
Global Markets for Breast Biopsy Devices 2009
US$ 11,495.00
The global markets for breast biopsy devices includes the spring loaded core needle market and vacuum assisted breast biopsy (VABB) market. The countries covered in this report include the U.S., Austria, Belgium, Denmark, France, Finland, Germany, Italy, Luxemburg, ...
September 2009
115 pages
Global Biomaterial Market (2009-2014)
US$ 5,650.00
... global biomaterial market as follows: Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others Biomaterials ingredient market Metals, polymers, ceramics, composites Biomaterials application market ...
September 2009
256 pages
Minimal Invasive and Non Invasive Product and Service Market (2009 - 2014)
US$ 5,650.00
... -edge medical technologies. This report uses the term ‘minimally invasive surgery’ to include non-invasive surgeries as well. The increasing demand of specialized treatment has ... report provides in-depth market estimates and forecast for global minimally invasive/non-invasive market as follows: • MIS market – products Surgical devices, monitoring and ...
September 2009
179 pages
Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)
US$ 5,650.00
... from standard drug and invasive surgical therapy. The neurostimulation market is driven mainly by technology advancements, rising consumer awareness, rising age-related neurological ... -invasive stimulation technology ) The market data consists of aggregate sales figures of all neurostimulation submarkets. It analyzes the market aspects of new neurostimulation technologies and product ...
September 2009
107 pages
Biosimilars (2009 - 2014)
US$ 5,650.00
... numerous opportunities in the global biosimilars market. The global biosimilars market is expected to be worth US$19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The biosimilars market is segmented into ... of the global biosimilars market. The American market is expected to dominate in 2014 after the U.S. market opens up in 2010. Currently, the global biosimilars market is highly ...
September 2009
189 pages
Probiotic Market - Advanced Technologies and Global Market (2009 - 2014)
US$ 5,650.00
... enhancement. Market estimates and forecast The report provides in-depth market estimates and forecast for global probiotics market as follows: ... is the market segmented in terms of applications, products, ingredients, technologies, stakeholders. • What are market estimates and forecast; which are markets are ...
September 2009
167 pages
Dental Equipment Market (2009 - 2014)
US$ 5,650.00
... market for dental implants and dental biomaterials will grow at an overall CAGR of 12.2% and 10.5% respectively from 2009 – 2014. The main driving element for global dental equipment market is the advancement in technologies that are available to dentists’ for treating their patients. The growth of this market is expected to be highest ...
September 2009
173 pages
Autoimmune Treatment (2009 - 2014)
US$ 5,650.00
... . The global market for autoimmune disease treatments is estimated to be at $37.84 billion in 2009, and is growing at a CAGR of 12.7% from 2009 to 2014 to reach an estimated $68.81 billion in 2014. The effects of the global ... 2009 to 2014. Scope of the Report The report provides market overviews and forecasts as well as market drivers and restraints for the global autoimmune treatment ...
September 2009
159 pages
Asia Medical Tourism Analysis (2008 - 2013)
US$ 1,000.00
Asia medical tourism industry has been growing with a double digit CAGR and expected to reach US$ 8.5 Billion by 2013. Thailand and India vie with each other for the medical tourism crown. Thailand’s...
September 2009
73 pages
Infectious Disease Diagnostic Markets
US$ 3,500.00
The ubiquity of infections makes thier detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population, and emerging threats - MRSA, swine flu, and others hav...
August 2009
180 pages
Pharma and Social Media -- the Leaders and Followers
US$ 295.00
The phenomenon of social media is seeing the creation of information and interest communities on an unparalled scale, and health is among the most popular.For pharmaceutical companies, the potential b...
August 2009
75 pages
Roche & Genentech: a Model for Future Biotech Deals?
US$ 295.00
Could this single deal mark a phase of big pharma/biotech consolidation? In March 2009, after months of negotiations, Roche acquired the 44 percent of shares that it did not already own in its long-t...
August 2009
42 pages
BMS & Medarex: a Valuable Partnership?
US$ 295.00
A positive move, but not one which deals with Bristol-Myers Squibb’s upcoming patent expiry problems On July 22, 2009, Bristol-Myers Squibb announced that it would acquire – at a considerable premium...
August 2009
Austrian Market for Dental Implants and Final Abutments 2009
US$ 4,495.00
In 2008, the Austrian market for dental implants and final abutments grew at double digit rates with future trends continuing this increase. The average selling price for Austrian dental implants was considerably higher than the European average.
August 2009
69 pages
Beleuxian Market for Dental Implants and Final Abutments 2009
US$ 4,495.00
The Beneluxian market for dental implants and final abutments, which includes Belgium, the Netherlands, and Luxembourg, is expected to grow at a higher growth rate than the European average. The Netherlands, having experienced rapid growth since 2005, represents two-thirds of the entire Beneluxian market.
August 2009
66 pages